DC
BCAB icon

Diametric Capital’s BioAtla BCAB Stock Holding History

Diametric Capital’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,670
Closed -$147K – 322
2024
Q3 		$147K Buy
+1,670
New +$140K 0.07% 326
2023
Q2 		– Sell
-326
Closed -$43.7K – 360
2023
Q1 		$43.7K Buy
+326
New +$58.7K 0.02% 311

Other funds holding BCAB

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Diametric Capital's BCAB Position: Q4 2024 in Review

Diametric Capital sold out of BioAtla (BCAB) in Q4 2024, closing a stake of 1,670 shares — an estimated $147K sold.

Diametric Capital first reported a position in BCAB in Q1 2023 and held it in 2 quarters. The position peaked at $147K in Q3 2024. 67 funds tracked by Wall St. Rank hold BCAB as of Q4 2024.

  • Diametric Capital reported no remaining BioAtla position as of Q4 2024 after selling out during the quarter.
  • Diametric Capital sold 1,670 BioAtla shares in Q4 2024, an estimated $147K.
  • Diametric Capital first reported a position in BioAtla in Q1 2023 and held it in 2 quarters.
  • Diametric Capital's BioAtla position peaked at $147K in Q3 2024.
  • 67 funds tracked by Wall St. Rank held BioAtla as of Q4 2024.

Based on Diametric Capital's 13F filing for Q4 2024, filed 12 Feb 2025.